{ "schema_version": 1, "kind": "condition", "id": "prostatitis", "name": "Acute bacterial prostatitis", "category": "infectious", "sources": "EAU Guidelines on Urological Infections 2023 · Egyptian National Drug Formulary - Antimicrobial 2023 (ofloxacin monograph, Indications naming Prostatitis and Dosage Regimen, Dosing: Adult usual adult dose), with the 2-to-4-week course from Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-full.txt) · Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-full.txt) · Egyptian National Drug Formulary - Antimicrobial 2023 (norfloxacin monograph, Dosage Regimen, Tablets: Adult dosing, Prostatitis)", "review_status": "reviewed", "verified_against": "Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-clinical.txt) · Egyptian National Drug Formulary - Antimicrobial 2023 (ofloxacin monograph, Indications naming Prostatitis and Dosage Regimen, Dosing: Adult usual adult dose), with the 2-to-4-week course from Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-full.txt) · Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-full.txt) · Egyptian National Drug Formulary - Antimicrobial 2023 (norfloxacin monograph, Dosage Regimen, Tablets: Adult dosing, Prostatitis)", "verified_date": "2026-08", "treatments": [ { "id": 1545, "generic": "Ciprofloxacin", "line": 1, "is_adjunct": false, "form": "oral.solid", "strength_mg": 500.0, "adult_dose": "500 mg orally twice daily", "adult_duration": "14-28 days", "dose_source": "Egyptian National Drug Formulary - Antimicrobial 2023", "rationale": "Ciprofloxacin is a fluoroquinolone antibiotic with good penetration into prostatic tissue, making it first-line for acute bacterial prostatitis; the extended course reflects the time needed for adequate clearance of infection from that tissue.", "cautions": [ "A minimum 14-day duration is required for adequate prostatic tissue penetration.", "Refer to urology if urinary retention or prostatic abscess suspected.", "There is a risk of tendonitis and peripheral neuropathy." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Condition restricted to adult males", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "QUINOLOROX 500MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EPCI > ROXXEN", "price_egp": 10.0, "pack_count": 10, "unit_price": 1.0, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "ECACIPROFLOX 500 MG 20 F.C. TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > EGYPTIAN CANADIAN PHARMACEUTICAL", "price_egp": 27.0, "pack_count": 20, "unit_price": 1.35, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "ELMODOXACIN 500MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EGPI > SEA PHARM", "price_egp": 20.0, "pack_count": 10, "unit_price": 2.0, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPROQUIN 500MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "UNIPHARMA", "price_egp": 50.0, "pack_count": 10, "unit_price": 5.0, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPROFLOXACIN-ORGANO 500 MG 10 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ORGANOPHARMA > ORGANO", "price_egp": 63.0, "pack_count": 10, "unit_price": 6.3, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPROFAR 500MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PHARCO", "price_egp": 69.0, "pack_count": 10, "unit_price": 6.9, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CIPROMEGA XL 500MG 10 EXT. REL. F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 48.0, "pack_count": null, "unit_price": null, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "HEROXACIN 500MG 10 SCORED F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EGPI > HERO PHARM", "price_egp": 69.0, "pack_count": null, "unit_price": null, "strength_mg": 500.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "prostatitis" }, { "id": 1546, "generic": "Referral & safety-netting (no drug therapy)", "line": 1, "is_adjunct": false, "form": null, "strength_mg": null, "adult_dose": null, "adult_duration": null, "dose_source": "Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-clinical.txt)", "rationale": "Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.", "cautions": [ "RED FLAG - Sepsis criteria, urinary retention, or risk factors for resistant organisms mean hospital admission and parenteral antibiotics, not the oral outpatient regimen." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": null, "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [], "condition_id": "prostatitis" }, { "id": 1547, "generic": "Ofloxacin", "line": 2, "is_adjunct": false, "form": "oral.solid", "strength_mg": 200.0, "adult_dose": "200 to 400 mg every 12 hours", "adult_duration": "2 to 4 weeks", "dose_source": "Egyptian National Drug Formulary - Antimicrobial 2023 (ofloxacin monograph, Indications naming Prostatitis and Dosage Regimen, Dosing: Adult usual adult dose), with the 2-to-4-week course from Acute Bacterial Prostatitis - disease-level clinical article (prostatitis-full.txt)", "rationale": "One document carries both claims. The Egyptian formulary's ofloxacin monograph names prostatitis in its own indication list and states a dose: for an adult, 200 to 400 mg, one dose every 12 hours. Ofloxacin is the alternative for a patient in whom ciprofloxacin is unsuitable. The course length is the disease article's, which puts oral fluoroquinolones at 2 to 4 weeks; the formulary attaches no duration to its prostatitis indication and the citation names both documents.", "cautions": [ "CONTRAINDICATED where the patient is hypersensitive to ofloxacin, to any other quinolone, or to any of the product's other ingredients.", "The formulary names prostatitis in ofloxacin's indications but states no prostatitis-specific regimen or duration. The 200 to 400 mg every 12 hours is its usual adult dose; the 2-to-4-week course is the disease article's figure for oral fluoroquinolones in acute bacterial prostatitis.", "Fluoroquinolone class risks apply: tendinitis and tendon rupture, peripheral neuropathy, CNS effects, QT prolongation and disordered glucose regulation.", "Separate from antacids, calcium, iron, magnesium and lanthanum - they block absorption.", "Severe hepatic impairment (for example cirrhosis with or without ascites): maximum 400 mg/day.", "Sepsis, urinary retention, or risk factors for resistant organisms mean admission and parenteral therapy, not an oral course." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Not for this indication in children. The formulary's paediatric ofloxacin dosing is for susceptible infection generally: children 15 mg/kg/day divided every 12 hours; children 45 kg and over and adolescents 300 to 400 mg twice daily.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "JEDCOFLACIN 200 MG 20 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "JEDCO INT. CO. FOR PHARMACEUTICALS", "price_egp": 43.25, "pack_count": 20, "unit_price": 2.16, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "OFLOXIN 200MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "KAHIRA", "price_egp": 21.6, "pack_count": 10, "unit_price": 2.16, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "OFLICIN 200MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS", "price_egp": 24.0, "pack_count": 10, "unit_price": 2.4, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "EPICOFLOCIN 200 MG 10 F.C.TABS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EIPICO", "price_egp": 28.0, "pack_count": 10, "unit_price": 2.8, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "OFLOXACIN 200MG 10 TAB", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "SEDICO", "price_egp": 30.0, "pack_count": 10, "unit_price": 3.0, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "KIROLL 200MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLAXO SMITHKLINE", "price_egp": 34.5, "pack_count": 10, "unit_price": 3.45, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "TARIVAN 200MG 10 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ALEXANDRIA", "price_egp": 44.0, "pack_count": 10, "unit_price": 4.4, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "TARIVID 200MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "SANOFI", "price_egp": 82.0, "pack_count": 10, "unit_price": 8.2, "strength_mg": 200.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "prostatitis" }, { "id": 1548, "generic": "Norfloxacin", "line": 2, "is_adjunct": false, "form": "oral.solid", "strength_mg": 400.0, "adult_dose": "400 mg every 12 hours", "adult_duration": "4 to 6 weeks", "dose_source": "Egyptian National Drug Formulary - Antimicrobial 2023 (norfloxacin monograph, Dosage Regimen, Tablets: Adult dosing, Prostatitis)", "rationale": "One document carries drug, dose AND duration. The Egyptian formulary's norfloxacin monograph prints an explicit prostatitis regimen in its own dosing table - by mouth, 400 mg every 12 hours, and the course runs 4 to 6 weeks - which is better sourced than the ofloxacin row beside it, whose 2-to-4-week course had to be taken from the disease article. The condition's article supplies the class-level indication: a patient who is not severely ill can go home on an oral fluoroquinolone or on Bactrim for 2 to 4 weeks, with a follow-up culture to confirm it has cleared. Seven Egyptian norfloxacin products are registered, six of them 400 mg tablets.", "cautions": [ "CONTRAINDICATED where the patient is hypersensitive to norfloxacin, to quinolones as a class, or to any of the product's other ingredients - and, for the tablets, where there is a past tendinitis or tendon rupture linked to a quinolone.", "The formulary's own Indications line for the tablets is narrower than its dosing table - it lists urinary tract infection, complicated or not, from susceptible gram-negative and gram-positive organisms. Prostatitis is named in the Dosage Regimen, not in that list, and the disease article is what recommends an oral fluoroquinolone for this condition.", "The formulary's course is 4 to 6 weeks and the article's is 2 to 4 weeks for oral fluoroquinolones generally; the row prints the formulary's, because that is the figure attached to prostatitis by name.", "Take with water on an empty stomach - 1 hour or more before food, or 2 hours after it; the same spacing applies to milk and other dairy. The instruction is the formulary's.", "Antacids, sucralfate and any multivitamin or supplement carrying iron, zinc, magnesium or aluminium must never be given at the same time as norfloxacin - separate them by 2 hours at least, either side of the dose.", "Renal impairment: at a CrCl of 30 mL/minute/1.73 m2 or below, the formulary gives 400 mg once daily.", "It is not to be used where there is a known aortic aneurysm, nor where the risk of one is raised - peripheral atherosclerotic vascular disease, hypertension, or an inherited disorder that alters the blood vessels. The warning is the formulary's.", "Fluoroquinolone class risks apply: tendinitis and tendon rupture, peripheral neuropathy, CNS effects, QT prolongation and disordered glucose regulation.", "Sepsis, urinary retention, or risk factors for resistant organisms mean admission and parenteral therapy, not an oral course." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Not for this indication in children, and the formulary states no oral paediatric norfloxacin dose at all - its only paediatric entry is the ophthalmic solution.", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "NORBACTIN 400MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "T3A PHARMA > RANBAXY", "price_egp": 17.4, "pack_count": 10, "unit_price": 1.74, "strength_mg": 400.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "NORMASH 400MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MASH PREMIERE", "price_egp": 18.0, "pack_count": 10, "unit_price": 1.8, "strength_mg": 400.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "NORACIN 400MG 10 F.C.TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "MEMPHIS", "price_egp": 22.68, "pack_count": 10, "unit_price": 2.27, "strength_mg": 400.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "EPINOR 400MG 14 TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EIPICO", "price_egp": 35.0, "pack_count": 14, "unit_price": 2.5, "strength_mg": 400.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "NEOFLOXIN 400MG 16 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ALEXANDRIA", "price_egp": 43.0, "pack_count": 16, "unit_price": 2.69, "strength_mg": 400.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "prostatitis" }, { "id": 1549, "generic": "Ceftriaxone", "line": 2, "is_adjunct": false, "form": "injection", "strength_mg": 1000.0, "adult_dose": "1 g by intramuscular injection as a single dose, given together with the doxycycline course, when a sexually transmitted cause is suspected", "adult_duration": "single IM dose", "dose_source": "Acute Bacterial Prostatitis - StatPearls - NCBI Bookshelf (NBK459257) for the indication and the regimen shape - verbatim: \"Patients who are suspected of a sexually transmitted cause of prostatitis should be treated with a single dose of intramuscular ceftriaxone followed by two weeks of doxycycline.\" That sentence gives no milligrams; the dose is from Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph) - verbatim: \"IV or IM 1-2 g once or devided twice daily\", 1 g vial.", "rationale": "Covers Neisseria gonorrhoeae, which the fluoroquinolones on this list no longer reliably treat. Paired with doxycycline for chlamydia.", "cautions": [ "Suspect a sexually transmitted cause in a younger man, with urethral discharge, or with a recent new partner - test for gonorrhoea and chlamydia before or alongside treatment.", "Treat the partner too, or the patient is reinfected.", "Do not give to a patient with a history of anaphylaxis to penicillin - the cross-reactivity is low but not zero, and this is an injection given in the clinic." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Condition restricted to adult males", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "ZOXIDEL 1 GM PD. FOR I.M. INJ.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "RAMEDA > DELTA PHARMA", "price_egp": 22.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA)", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "KAHIRA", "price_egp": 29.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "ZOXIDEL 1 GM PD. FOR I.V. INJ.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "RAMEDA > DELTA PHARMA", "price_egp": 29.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "WINTRIAXONE 1 GM PD. FOR I.V INJ.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "SANOFI", "price_egp": 48.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VOTRIAXONE 1 GM I.M VIAL", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "CHEMIPHARM", "price_egp": 56.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "OFRAMAX 1 GM I.M. VIAL", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "RAMEDA > SUN PHARMA EGYPT LIMITED", "price_egp": 71.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "TRIAXONE 1 GM I.M. VIAL", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA", "price_egp": 106.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "TRIAXONE 1 GM I.V VIAL", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA", "price_egp": 106.0, "pack_count": null, "unit_price": null, "strength_mg": 1000.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "prostatitis" }, { "id": 1550, "generic": "Doxycycline", "line": 2, "is_adjunct": false, "form": "oral.solid", "strength_mg": 100.0, "adult_dose": "100 mg orally twice daily, started with the ceftriaxone dose, when a sexually transmitted cause is suspected", "adult_duration": "14 days", "dose_source": "Acute Bacterial Prostatitis - StatPearls - NCBI Bookshelf (NBK459257) for the indication and the two-week course - verbatim: \"Patients who are suspected of a sexually transmitted cause of prostatitis should be treated with a single dose of intramuscular ceftriaxone followed by two weeks of doxycycline.\" Milligrams from Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) - verbatim: \"Usual dosage range: Oral: IR and most ER formulations: 100 to 200 mg/day in 1 to 2 divided doses\", 100 mg capsules.", "rationale": "Covers Chlamydia trachomatis and the other atypical organisms, and reaches the prostate. The full two weeks matters - a shorter course relapses.", "cautions": [ "Take with a full glass of water, sitting upright, and not at bedtime - it causes oesophageal ulceration otherwise.", "Causes photosensitivity. Relevant in Cairo: advise sun protection over the fortnight.", "Separate from antacids, iron, and dairy by two hours, which otherwise bind it and stop it being absorbed." ], "peds_mgkg_low": null, "peds_mgkg_high": null, "peds_max_mg": null, "peds_basis": null, "peds_unit": null, "peds_note": "Condition restricted to adult males", "peds_min_weight_kg": null, "peds_max_weight_kg": null, "peds_age_min_months": null, "peds_age_max_months": null, "peds_age_bands": null, "peds_doses": null, "brands": [ { "trade_name": "FARCODOXIN 100MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PHARCO", "price_egp": 11.0, "pack_count": 10, "unit_price": 1.1, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DOXY M.R.100 MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "ADWIA", "price_egp": 12.0, "pack_count": 10, "unit_price": 1.2, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "GRANUDOXY 100MG 10 F.C. TAB.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "GLOBAL NAPI PHARMACEUTICALS > PIERRE FRANCE", "price_egp": 12.0, "pack_count": 10, "unit_price": 1.2, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DOXYDOX 100 MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EIPICO", "price_egp": 23.0, "pack_count": 10, "unit_price": 2.3, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "DOXYMYCIN 100 MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "EL NILE.", "price_egp": 30.0, "pack_count": 10, "unit_price": 3.0, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "TABOCINE 100MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA", "price_egp": 46.0, "pack_count": 10, "unit_price": 4.6, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null }, { "trade_name": "VIBRAMYCIN 100MG 10 CAPS.", "scientific_name": null, "normalized_ingredient": null, "manufacturer": "PFIZER", "price_egp": 65.0, "pack_count": 10, "unit_price": 6.5, "strength_mg": 100.0, "exact_strength": true, "exact_form": true, "discontinued": false, "also_contains": null } ], "condition_id": "prostatitis" } ] }